Imricor Medical Systems Future Growth
Future criteria checks 2/6
Imricor Medical Systems is forecast to grow earnings and revenue by 36.4% and 72.5% per annum respectively while EPS is expected to grow by 49.2% per annum.
Key information
36.4%
Earnings growth rate
49.2%
EPS growth rate
| Medical Equipment earnings growth | 16.6% |
| Revenue growth rate | 72.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 02 May 2024 |
Recent future growth updates
Recent updates
Does Imricor Medical Systems (ASX:IMR) Have A Healthy Balance Sheet?
Jun 17
Here's Why Imricor Medical Systems (ASX:IMR) Must Use Its Cash Wisely
Jul 08Will Imricor Medical Systems (ASX:IMR) Spend Its Cash Wisely?
Mar 23We're Hopeful That Imricor Medical Systems (ASX:IMR) Will Use Its Cash Wisely
May 09When Will Imricor Medical Systems, Inc. (ASX:IMR) Turn A Profit?
Feb 28We Think Imricor Medical Systems (ASX:IMR) Needs To Drive Business Growth Carefully
Jan 24What Is The Ownership Structure Like For Imricor Medical Systems, Inc. (ASX:IMR)?
Dec 02
What You Need To Know About Imricor Medical Systems, Inc.'s (ASX:IMR) Investor Composition
Aug 18Analysts Expect Breakeven For Imricor Medical Systems, Inc. (ASX:IMR)
Jun 25Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 17 | -7 | -9 | -9 | 1 |
| 12/31/2025 | 9 | -11 | -13 | -12 | 1 |
| 12/31/2024 | 4 | -14 | -13 | -13 | 1 |
| 12/31/2023 | 1 | -23 | -13 | -13 | N/A |
| 9/30/2023 | 1 | -20 | -14 | -14 | N/A |
| 6/30/2023 | 0 | -17 | -14 | -14 | N/A |
| 3/31/2023 | 1 | -17 | -16 | -15 | N/A |
| 12/31/2022 | 1 | -17 | -17 | -17 | N/A |
| 9/30/2022 | 1 | -18 | -17 | -17 | N/A |
| 6/30/2022 | 1 | -20 | -17 | -17 | N/A |
| 3/31/2022 | 1 | -20 | -18 | -17 | N/A |
| 12/31/2021 | 1 | -20 | -18 | -17 | N/A |
| 9/30/2021 | 1 | -18 | -17 | -16 | N/A |
| 6/30/2021 | 1 | -17 | -16 | -15 | N/A |
| 3/31/2021 | 1 | -15 | -15 | -14 | N/A |
| 12/31/2020 | 1 | -12 | -13 | -12 | N/A |
| 9/30/2020 | 1 | -13 | -12 | -11 | N/A |
| 6/30/2020 | 1 | -14 | -10 | -9 | N/A |
| 3/31/2020 | 1 | -14 | -9 | -8 | N/A |
| 12/31/2019 | 1 | -13 | -7 | -7 | N/A |
| 9/30/2019 | 1 | -11 | -6 | -6 | N/A |
| 6/30/2019 | 0 | -8 | -6 | -5 | N/A |
| 3/31/2019 | 1 | -7 | -5 | -5 | N/A |
| 12/31/2018 | 1 | -5 | -5 | -5 | N/A |
| 12/31/2017 | 0 | -5 | -4 | -4 | N/A |
| 12/31/2016 | 1 | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IMR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IMR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IMR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IMR's revenue (72.5% per year) is forecast to grow faster than the Australian market (4.8% per year).
High Growth Revenue: IMR's revenue (72.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IMR's Return on Equity is forecast to be high in 3 years time